SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.
SynOx Therapeutics has raised $92.0M in total funding. The most recent round was Series B. The last funding was announced in October 2024.
SynOx Therapeutics's investors include HealthCap, Forbion Capital Partners, Hercules Capital, Medicxi, Gilde Healthcare.
SynOx Therapeutics is headquartered in Dublin, Ireland.
SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.
SynOx Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SynOx Therapeutics — Funding & Investors." VCBacked, October 30, 2024, https://www.vcbacked.co/company/synox-therapeutics. Accessed August 15, 2026.
VCBacked. (2024). SynOx Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/synox-therapeutics
{{cite web |title=SynOx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/synox-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated